Q-Line Biotech IPO 2026 – Full Details, GMP, Allotment Date, Analysis

Today, the Lucknow-based IVD diagnostics company opens its ₹214.48 Cr NSE SME IPO. Everything you want to know before applying.

IPO Open: 21 May 2026 IPO Close: 25 May 2026 Listing: 29 May 2026 Price Band: ₹326-₹343

Q-Line Biotech IPO — Quick Facts at a Glance

Track Q-Line Biotech IPO GMP live on IPO Ji — updated daily. Check GMP on IPOji →

IPO Timeline

Lot Size & Investment Amount

All amounts calculated at the upper price band of ₹343 per share.

Please note: This is NSE SME IPO hence minimum retail application is 2 lots (800 shares). Entry ticket of ₹2,74,400 is much higher than a normal mainboard IPO. Make sure you have this amount ASBA blocked in your bank before you apply.

About Q-Line Biotech — Who Are They?

Q-Line Biotech Limited was founded in 2010 and is based in Lucknow, Uttar Pradesh. The company is in the In-Vitro Diagnostics (IVD) space — which basically means they make the kits, reagents and instruments used in medical labs to test blood, urine and other biological samples.

They began offering diagnostic instruments and IVD products in 2013, supplying diagnostic service organizations, hospitals and medical colleges directly or via distributors. Over the years they’ve built a manufacturing setup across multiple categories:

Clinical Chemistry Reagent;

Reagents for hematology

Immunodiagnostics 

Molecular Diagnostics &

POC (Point-of-Care) Devices & Quick Tests

Manufacture and supply of pathologic equipment and in-vitro diagnostic (IVD) devices. As on March 2025, the company had 313 permanent employees on its rolls.

The company is promoted by Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty and Abhay Agrawal. In simple words, Q-Line Biotech is a part of the backbone of India’s diagnostic industry. It's quite possible that every time you get a blood test or rapid test run at a lab, they are using some sort of equipment or reagents from a company like this.

Q-Line Biotech Financial Snapshot

A few notable points can be observed. First, the income has increased significantly between FY24 and FY25.(₹206 Cr in FY24, ₹322 Cr in FY25), indicating growth and expansion of the firm's operations. At the same time, the profit after tax for FY25, ₹28 Cr, was less than in FY24 (₹34 Cr). The improvement in profits, however, can be seen based on the 9 months FY26 PAT of ₹38.69 Cr, surpassing FY25 PAT figures altogether.

As far as the debt situation is concerned, the level of borrowings has increased from ₹73 Cr in FY23 to ₹243 Cr at the end of December 2025. Therefore, debt reduction is one of the key objectives of this IPO.

Objectives behind the IPO – How will the money be utilized?

The following are the three main objectives behind which this
IPO is being conducted. These require that the ₹214.48 Crore collected via this IPO be utilized as follows:

Working capital needs – ₹93.50 Crore

Repayment of certain borrowings – ₹90.00 Crore

Other corporate purposes – remaining sum

Approximately ₹183.50 Crore from the total amount will go into working capital and repayment of debts. Such a distribution is quite normal considering that the company operates in the manufacturing sector.

Subscription Status (Live)
Q-Line Biotech IPO subscription data as of May 21, 2026, 5:00 PM:

The IPO is showing decent early traction with overall subscription at 4.11x on Day 1. QIBs leading at 4.15x is a strong early signal — institutional interest this early in the subscription window is generally a positive indicator.

Track live Q-Line Biotech IPO subscription on IPOji →

Allotment Details

Registrar: Purva Sharegistry (India) Pvt. Ltd. Registrar Website: www.purvashare.com Registrar Email: newissue@purvashare.com

To check your allotment status, visit the Purva Sharegistry website after May 26 and enter your PAN number or application number. You can also check it directly on IPOji — free, no login required.

Check Q-Line Biotech IPO allotment status on IPOji →

How to Apply for Q-Line Biotech IPO

Step 1 - Open your broker /bank App You can use IPO Ji , Zerodha , Groww, Angel One, Upstox or your bank's net banking portal. Go to IPO section there.

Step 2 - Search for "Q-Line Biotech IPO" It is active from 21st May, 2026. Choose the number of lots to bid on - Minimum 2 lots ( 800 shares valued at Rs 2,74,400 at upper band ). You can also apply using IPO Ji by linking your demat account.

Step 3 - Bid at the cut off price Bid at the cut off price of Rs 343 for maximum chance of allotment. Amount is only blocked in your account and not debited till you are allotted.

Step 4 - Enter your UPI ID and accept the mandate After you place the order, a UPI mandate request will appear on your payapp (GPay, PhonePe, BHIM, Paytm). Approve the same before it gets expired.

Step 5 - Check allotment on 26th May You can check your allotment from IPO Ji or Purva Sharegistry. Enter your PAN/application number and check your allotment.

Contact & Registrar Details

Frequently Asked Questions

Conclusion

Q-Line Biotech is a profitable diagnostics firm, experiencing rising revenues and operations in one of the sturdier business environments of India. The IPO model, which comprises all fresh issuance, with proceeds to be allocated for working capital purposes and debts, is clean.

Having said that, the offering comes from an SME IPO with a hefty entry price, substantial debt, and some concerns about margin stability. Investors should evaluate the risks carefully before applying. Research thoroughly, analyze the RHP, and make your own judgment.

Monitor the real-time GMP, subscriptions status, and allotments for Q-Line Biotech IPO at ipoji.com 

Disclaimer: This blog is published on IPOji.com for informational and educational purposes only. It does not constitute investment advice. GMP data is unofficial and sourced from market sentiment — it does not guarantee listing price or returns. Please read the Red Herring Prospectus (RHP) carefully before investing. IPOji is not SEBI registered. Consult your financial advisor before making any investment decision.